ACE and COVID-19: They evaluated the evidence linking COVID-19 and ACE1 polymorphisms, and found contradictory results; this is because some researchers have stated that the DD genotype adversely affects COVID-19 symptoms, while others suggest ACE1 II genotype as the risk factor.